| Bioactivity | BPI-15086 an orally active, potent, irreversible mutant-selective inhibitor of both EGFR and T790M resistance mutations tyrosine kinase. BPI-15086 can be used for the research of non-small-cell lung cancer[1]. |
| CAS | 1644502-33-9 |
| Formula | C29H33ClN8O4 |
| Molar Mass | 593.08 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wang S, et al. Determination of BPI15086 and its metabolite in human plasma by ultra-high performance liquid chromatography-MS/MS and its application to a pharmacokinetic study. Bioanalysis. 2019 Apr;11(8):773-784. |
BPI-15086
CAS: 1644502-33-9 F: C29H33ClN8O4 W: 593.08
BPI-15086 an orally active, potent, irreversible mutant-selective inhibitor of both EGFR and T790M resistance mutations
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.